Biblio Discovery — Demo Discovery Service

25 results for "Krishna Pandey"

Showing 1–20 · 0.23 seconds · RSS

  1. Journal Article Full text

    Knowledge, stigma, health seeking behaviour and its determinants among patients with post kalaazar dermal leishmaniasis, Bihar, India

    Pavan Garapati; Biplab Pal; Niyamat Ali Siddiqui et al.

    PLOS ONE, Vol. 13 No. 9 · 2018 · English · PLOS Scopus

    Background: Lesishmaniasis is a neglected tropical disease endemic in Bihar, India. Inappropriate health seeking behaviour of post kala-azar dermal leishmaniasis (PKDL) patients may increase the disease duration, severity and transmissibility. Simultaneously, lack of knowledge and perceived stigma…

  2. Journal Article Full text

    Impact of ASHA Training on Active Case Detection of Visceral Leishmaniasis in Bihar, India

    Vidya Nand Ravi Das; Ravindra Nath Pandey; Krishna Pandey et al.

    PLoS Neglected Tropical Diseases, Vol. 8 No. 5 · 2014 · English · PLOS Scopus

    Background: One of the major challenges for management of visceral leishmaniasis (VL) is early diagnosis of cases to improve treatment outcome and reduce transmission. We have therefore investigated active case detection of VL with the help of accredited social health activists (ASHA). ASHAs are…

  3. Journal Article Full text

    Hepatitis C virus seroprevalence among patients enrolled at the opioid substitution therapy center in Bihar: A cross-sectional study

    Ashish Kumar; Hemant Mahajan; Sanjay Chaturvedi et al.

    PLOS ONE, Vol. 18 No. 6 · 2023 · English · PLOS Scopus

    Background and aim: Hepatitis C virus (HCV) infection poses a major public health challenge in Indian settings due to its huge population and easy transmissibility of HCV among individuals who inject drugs (PWID, which is increasing in India). The National AIDS Control Organization (NACO), India…

  4. Journal Article Full text

    Diagnosis of Visceral Leishmaniasis in Bihar India: Comparison of the rK39 Rapid Diagnostic Test on Whole Blood Versus Serum

    Greg Matlashewski; Vidya Nand Ravi Das; Krishna Pandey et al.

    PLoS Neglected Tropical Diseases, Vol. 7 No. 5 · 2013 · English · PLOS Scopus

    Background: Antibody-detecting rapid diagnostic tests (RDTs) against rK39 are available to aid in the diagnosis of visceral leishmaniasis (VL). Although these rK39 RDTs have been developed, validated and approved for use with serum, they are universally performed using whole blood. It was therefore…

  5. Journal Article Full text

    Prevalence and determinants of asymptomatic Leishmania infection in HIV-infected individuals living within visceral leishmaniasis endemic areas of Bihar, India

    Raman Mahajan; Sophie I. Owen; Shiril Kumar et al.

    PLOS Neglected Tropical Diseases, Vol. 16 No. 8 · 2022 · English · PLOS Scopus

    People living with HIV (PLHIV) have an increased risk of developing visceral leishmaniasis (VL) and poor outcomes compared to HIV negative individuals. Here, we aim to establish the prevalence and determinants of asymptomatic Leishmania infection (ALI) in a cohort of PLHIV in Bihar, India. We hoped…

  6. Journal Article Full text

    Knowledge, attitude and practices towards visceral leishmaniasis among HIV patients: A cross-sectional study from Bihar, India

    Devipriya J. S.; Ashok Kumar Gupta; Rajendra Babu Veeri et al.

    PLOS ONE, Vol. 16 No. 8 · 2021 · English · PLOS Scopus

    Background: In the Indian state of Bihar, visceral leishmaniasis (VL) is a major public health issue that has been aggravated by the rising incidence of new Human immunodeficiency virus (HIV) infections. In endemic areas, the risk of VL infections in patients living with HIV (PLHIV) is higher. It…

  7. Journal Article Full text

    Longitudinal Study of Transmission in Households with Visceral Leishmaniasis, Asymptomatic Infections and PKDL in Highly Endemic Villages in Bihar, India

    Vidya Nand Ravi Das; Ravindra Nath Pandey; Niyamat Ali Siddiqui et al.

    PLOS Neglected Tropical Diseases, Vol. 10 No. 12 · 2016 · English · PLOS Scopus

    Background: Visceral Leishmaniasis (VL) is a neglected tropical disease that afflicts some of the poorest populations in the world including people living in the Bihar state of India. Due to efforts from local governments, NGOs and international organizations, the number of VL cases has declined in…

  8. Journal Article Full text

    Induction of IL-10 and TGFβ from CD4 + CD25 + FoxP3 + T Cells Correlates with Parasite Load in Indian Kala-azar Patients Infected with Leishmania donovani

    Pradyot Bhattacharya; Smriti Ghosh; Sarfaraz Ahmad Ejazi et al.

    PLOS Neglected Tropical Diseases, Vol. 10 No. 2 · 2016 · English · PLOS Scopus

    Background: Visceral leishmaniasis (VL) is distinguished by a complex interplay of immune response and parasite multiplication inside host cells. However, the direct association between different immunological correlates and parasite numbers remains largely unknown. Methodology/Principal Findings…

  9. Journal Article Full text

    To evaluate efficacy and safety of amphotericin B in two different doses in the treatment of post kala-azar dermal leishmaniasis (PKDL)

    Vidya Nand Rabi Das; Niyamat Ali Siddiqui; Biplab Pal et al.

    PLOS ONE, Vol. 12 No. 3 · 2017 · English · PLOS Scopus

    Background: Post kala-azar dermal leishmaniasis (PKDL) is a skin disorder that usually occurs among patients with a past history of visceral leishmaniasis (VL). Cases are also reported without a history of VL. There is no satisfactory treatment regimen available at present. We aimed to compare the…

  10. Journal Article Full text

    Efficacy and Safety of Amphotericin B Emulsion versus Liposomal Formulation in Indian Patients with Visceral Leishmaniasis: A Randomized, Open-Label Study

    Shyam Sundar; Krishna Pandey; Chandreshwar Prasad Thakur et al.

    PLoS Neglected Tropical Diseases, Vol. 8 No. 9 · 2014 · English · PLOS Scopus

    Background: India is home to 60% of the total global visceral leishmaniasis (VL) population. Use of long-term oral (e.g. miltefosine) and parenteral drugs, considered the mainstay for treatment of VL, is now faced with increased resistance, decreased efficacy, low compliance and safety issues. The…

  11. Journal Article Full text

    Chronic Arsenic Exposure and Risk of Post Kala-azar Dermal Leishmaniasis Development in India: A Retrospective Cohort Study

    Sushmita Das; Rakesh Mandal; Vidya Nand Rabidas et al.

    PLOS Neglected Tropical Diseases, Vol. 10 No. 10 · 2016 · English · PLOS Scopus

    Background: Visceral leishmaniasis (VL), with the squeal of Post-kala-azar dermal leishmaniasis (PKDL), is a global threat for health. Studies have shown sodium stibogluconate (SSG) resistance in VL patients with chronic arsenic exposure. Here, we assessed the association between arsenic exposure…

  12. Journal Article Full text

    Noninvasive Diagnosis of Visceral Leishmaniasis: Development and Evaluation of Two Urine-Based Immunoassays for Detection of Leishmania donovani Infection in India

    Sarfaraz Ahmad Ejazi; Pradyot Bhattacharya; Md. Asjad Karim Bakhteyar et al.

    PLOS Neglected Tropical Diseases, Vol. 10 No. 10 · 2016 · English · PLOS Scopus

    Background: Visceral Leishmaniasis (VL), a severe parasitic disease, could be fatal if diagnosis and treatment is delayed. Post kala-azar dermal leishmaniasis (PKDL), a skin related outcome, is a potential reservoir for the spread of VL. Diagnostic tests available for VL such as tissue aspiration…

  13. Journal Article Full text

    Kala-azar elimination in a highly-endemic district of Bihar, India: A success story

    Vijay Kumar; Rakesh Mandal; Sushmita Das et al.

    PLOS Neglected Tropical Diseases, Vol. 14 No. 5 · 2020 · English · PLOS Scopus

    Background: Visceral leishmaniasis (VL) or Kala-azar has been a major public health problem in Bihar, India, for several decades. A few VL infected districts including Vaishali have reported >600 cases annually. Hence, in 2015, the Government of India entrusted ICMR-Rajendra Memorial Research…

  14. Journal Article Full text

    Advanced case of PKDL due to delayed treatment: A rare case report

    Roshan Kamal Topno; Vidya Nand Rabi Das; Maneesh Kumar et al.

    PLOS Neglected Tropical Diseases, Vol. 14 No. 3 · 2020 · English · PLOS Scopus

    Post-kala-azar dermal leishmaniasis (PKDL) is clinical outcome of visceral leishmaniasis (VL) and is thought to be the potential reservoir of parasite. Miltefosine (MF) is the only oral drug existing for treatment of post-kala-azar dermal leishmaniasis (PKDL). Increased miltefosine tolerance in…

  15. Journal Article Full text

    Long-term incidence of relapse and post-kala-azar dermal leishmaniasis after three different visceral leishmaniasis treatment regimens in Bihar, India

    Vishal Goyal; Vidya Nand Rabi Das; Shambhu Nath Singh et al.

    PLOS Neglected Tropical Diseases, Vol. 14 No. 7 · 2020 · English · PLOS Scopus

    Background: Few prospective data exist on incidence of post kala-azar dermal leishmaniasis (PKDL) and visceral leishmaniasis (VL) relapse after different treatment regimens. Methodology/Principal findings: A Phase IV trial included 1761 VL patients treated between 2012–2014 with single dose…

  16. Journal Article Full text

    Visceral Leishmaniasis and HIV Co-infection in Bihar, India: Long-term Effectiveness and Treatment Outcomes with Liposomal Amphotericin B (AmBisome)

    Sakib Burza; Raman Mahajan; Prabhat K. Sinha et al.

    PLoS Neglected Tropical Diseases, Vol. 8 No. 8 · 2014 · English · PLOS Scopus

    Background: Visceral Leishmaniasis (VL; also known as kala-azar) is an ultimately fatal disease endemic in the Indian state of Bihar, while HIV/AIDS is an emerging disease in this region. A 2011 observational cohort study conducted in Bihar involving 55 VL/HIV co-infected patients treated with…

  17. Journal Article Full text

    Improved kala-azar case management through implementation of health facility-based sentinel sites surveillance system in Bihar, India

    Vidya Nand Rabi Das; Niyamat Ali Siddiqui; Gouri Sankar Bhunia et al.

    PLOS Neglected Tropical Diseases, Vol. 15 No. 8 · 2021 · English · PLOS Scopus

    Background: Visceral leishmaniasis (VL), also known as kala-azar (KA), is a neglected vector-borne disease, targeted for elimination, but several affected blocks of Bihar are posing challenges with the high incidence of cases, and moreover, the disease is spreading in newer areas. High-quality…

  18. Journal Article Full text

    Conversion of asymptomatic infection to symptomatic visceral leishmaniasis: A study of possible immunological markers

    Vidya Nand Rabi Das; Sanjiva Bimal; Niyamat Ali Siddiqui et al.

    PLOS Neglected Tropical Diseases, Vol. 14 No. 6 · 2020 · English · PLOS Scopus

    Introduction: Presence of asymptomatic individuals in endemic areas is common. The possible biomarkers in asymptomatic individuals once they get exposed to infection as well as following conversion to symptomatic disease are yet to be identified.We identified asymptomatic Visceral leishmaniasis…

  19. Journal Article Full text

    Identification of Leishmania donovani antigen in circulating immune complexes of visceral leishmaniasis subjects for diagnosis

    Fauzia Jamal; Pushkar Shivam; Sarita Kumari et al.

    PLOS ONE, Vol. 12 No. 8 · 2017 · English · PLOS Scopus

    The unreliability of most of the existing antibody-based diagnostic kits to discriminate between active and treated VL cases, relapse situation and reinfection are a major hurdle in controlling the cases of Kala-azar in an endemic area. An antigen targeted diagnostic approaches can be an attractive…

  20. Journal Article Full text

    Field effectiveness of new visceral leishmaniasis regimens after 1 year following treatment within public health facilities in Bihar, India

    Vishal Goyal; Sakib Burza; Krishna Pandey et al.

    PLOS Neglected Tropical Diseases, Vol. 13 No. 9 · 2019 · English · PLOS Scopus

    Background: An earlier open label, prospective, non-randomized, non-comparative, multi-centric study conducted within public health facilities in Bihar, India (CTRI/2012/08/002891) measured the field effectiveness of three new treatment regimens for visceral leishmaniasis (VL): single dose AmBisome…